Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.

Mischoulon D, Best-Popescu C, Laposata M, Merens W, Murakami JL, Wu SL, Papakostas GI, Dording CM, Sonawalla SB, Nierenberg AA, Alpert JE, Fava M.

Eur Neuropsychopharmacol. 2008 Sep;18(9):639-45. doi: 10.1016/j.euroneuro.2008.04.011. Epub 2008 Jun 6.

PMID:
18539007
2.

Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?

Kotzalidis G, Pacchiarotti I, Manfredi G, Savoja V, Torrent C, Mazzarini L, Tatarelli C, Amann B, Di Marzo S, Sánchez-Moreno J, Sani G, Girardi P, Colom F, Vieta E.

J Psychopharmacol. 2008 Aug;22(6):590-7. doi: 10.1177/0269881108089576. Epub 2008 May 30.

PMID:
18515445
3.

Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.

Su KP, Huang SY, Chiu TH, Huang KC, Huang CL, Chang HC, Pariante CM.

J Clin Psychiatry. 2008 Apr;69(4):644-51.

PMID:
18370571
4.

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT.

PLoS Med. 2008 Feb;5(2):e45. doi: 10.1371/journal.pmed.0050045.

5.

Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?

Elliott C.

New Yorker. 2008 Jan 7:36-41. No abstract available.

PMID:
18265451
6.

Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial.

Rees AM, Austin MP, Parker GB.

Aust N Z J Psychiatry. 2008 Mar;42(3):199-205. doi: 10.1080/00048670701827267. Erratum in: Aust N Z J Psychiatry. 2008 May;42(5):438.

PMID:
18247194
7.

Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.

Jazayeri S, Tehrani-Doost M, Keshavarz SA, Hosseini M, Djazayery A, Amini H, Jalali M, Peet M.

Aust N Z J Psychiatry. 2008 Mar;42(3):192-8. doi: 10.1080/00048670701827275.

PMID:
18247193
8.

Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study.

Freeman MP, Davis M, Sinha P, Wisner KL, Hibbeln JR, Gelenberg AJ.

J Affect Disord. 2008 Sep;110(1-2):142-8. doi: 10.1016/j.jad.2007.12.228. Epub 2008 Feb 21.

PMID:
18206247
9.

Selective publication of antidepressant trials and its influence on apparent efficacy.

Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R.

N Engl J Med. 2008 Jan 17;358(3):252-60. doi: 10.1056/NEJMsa065779.

10.

Tolerability of omega-3 fatty acid supplements in perinatal women.

Freeman MP, Sinha P.

Prostaglandins Leukot Essent Fatty Acids. 2007 Oct-Nov;77(3-4):203-8. Epub 2007 Nov 5.

PMID:
17981449
11.

No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial.

Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, Hayward RC, Heatherley SV, Christian LM, McNaughton SA, Ness AR.

Br J Nutr. 2008 Feb;99(2):421-31. Epub 2007 Oct 24.

PMID:
17956647
12.
13.
14.

Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial.

Grenyer BF, Crowe T, Meyer B, Owen AJ, Grigonis-Deane EM, Caputi P, Howe PR.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1393-6. Epub 2007 Jun 19.

PMID:
17659823
15.

A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences.

Hunot VM, Horne R, Leese MN, Churchill RC.

Prim Care Companion J Clin Psychiatry. 2007;9(2):91-9.

16.
17.

Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.

Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE Jr, Marangell LB, Richardson AJ, Lake J, Stoll AL.

J Clin Psychiatry. 2006 Dec;67(12):1954-67. Review. Erratum in: J Clin Psychiatry. 2007 Feb;68(2):338.

PMID:
17194275
18.

Distribution, interconversion, and dose response of n-3 fatty acids in humans.

Arterburn LM, Hall EB, Oken H.

Am J Clin Nutr. 2006 Jun;83(6 Suppl):1467S-1476S. Review.

19.

Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk.

Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ.

Am J Psychiatry. 2006 Jun;163(6):1100-2.

PMID:
16741213
20.

Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.

Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH.

Am J Psychiatry. 2006 Jun;163(6):1098-100.

PMID:
16741212

Supplemental Content

Support Center